SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

CIPLA

BSE: 500087 28 Sep 2025
Healthcare
₹ 1549
Cipla Ltd., specializes in Pharmaceuticals within the Healthcare sector.

CIPLA - Share Price & Details

Market Cap
₹1,21,115
High /Low
1,702 / 1,310
Stock P/E
22.5
Book Value
₹386.0
Dividend Yield
0.87
ROCE
22.7
ROE
₹17.8
Face Value
2.0
PEG Ratio
0.87
EVEBITDA
₹14.8
Debt
438
CMP / FCF
43.2
Debt to equity
₹0.01
NP Ann
5,269
High price all time
1,702
Piotroski score
₹7.0
Graham Number
762.0
No. Eq. Shares
80.8
Net CF
₹30.3
Net profit
5,385
Price to book value
3.88
Interest Coverage
₹121.0
Low price all time
84.7
Industry PE
33.0
Reserves
₹31,032
Free Cash Flow
₹3,490

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
08 Sep 2025 Deven Choksey Hold ₹1,541.4 ₹1,570 1.8% moneycontrol View
02 Sep 2025 Mirae Asset Sharekhan Buy ₹1,568.95 ₹1,754 11.1% moneycontrol View
27 Jul 2025 Prabhudas Lilladher Buy ₹1,531.1 ₹1,730 9.9% moneycontrol View
26 Jul 2025 ICICI Securities Buy ₹1,531.1 ₹1,800 14.3% moneycontrol View
14 May 2025 Prabhudas Lilladher Buy ₹1,495.4 ₹1,730 15.1% moneycontrol View
11 Apr 2025 Prabhudas Lilladher Buy ₹1,416.3 ₹1,730 18.2% moneycontrol View
31 Jan 2025 KRChoksey Buy ₹1,458.15 ₹1,598 8% moneycontrol View
29 Jan 2025 Prabhudas Lilladher Buy ₹1,423.95 ₹1,730 18.7% moneycontrol View
28 Jan 2025 Motilal Oswal Hold ₹1,419.55 ₹1,530 4.9% moneycontrol View
17 Jan 2025 Asit C. Mehta Buy ₹1,442.45 ₹1,808 27.2% moneycontrol View
04 Dec 2024 Geojit Financial Services Buy ₹1,501.1 ₹1,695 13.1% moneycontrol View
28 Nov 2024 Prabhudas Lilladher Buy ₹1,492.85 ₹1,730 12% moneycontrol View
04 Nov 2024 KRChoksey Buy ₹1,584.55 ₹1,680 8.8% moneycontrol View
30 Oct 2024 Prabhudas Lilladher Buy ₹1,417.45 ₹1,615 4.6% moneycontrol View
29 Oct 2024 Sharekhan Buy ₹1,478.1 ₹1,715 11% moneycontrol View
02 Aug 2024 KRChoksey Buy ₹1,528.8 ₹1,633 6.4% moneycontrol View
28 Jul 2024 Prabhudas Lilladher Buy ₹1,578.25 ₹1,680 9.5% moneycontrol View
26 Jul 2024 Motilal Oswal Buy ₹1,578.25 ₹1,830 19.3% moneycontrol View
26 Jun 2024 Motilal Oswal Buy ₹1,479.45 ₹1,700 10.8% moneycontrol View
16 May 2024 Sharekhan Buy ₹1,420.05 ₹1,600 4.3% moneycontrol View
13 May 2024 KRChoksey Buy ₹1,414.8 ₹1,633 6.4% moneycontrol View
11 May 2024 Prabhudas Lilladher Buy ₹1,339.45 ₹1,405 -8.4% moneycontrol View
10 May 2024 Motilal Oswal Buy ₹1,339.45 ₹1,600 4.3% moneycontrol View
14 Mar 2024 Sharekhan Buy ₹1,497.05 ₹1,700 10.8% moneycontrol View
29 Jan 2024 KRChoksey Buy ₹1,337.25 ₹1,592 3.7% moneycontrol View
26 Jan 2024 ICICI Securities Buy ₹1,369.8 ₹1,660 8.2% moneycontrol View
26 Jan 2024 Prabhudas Lilladher Buy ₹1,369.8 ₹1,400 -8.7% moneycontrol View
25 Jan 2024 Motilal Oswal Buy ₹1,369.8 ₹1,600 4.3% moneycontrol View
16 Jan 2024 Motilal Oswal Buy ₹1,301.45 ₹1,540 0.3% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
CIPLA LTD.53172.413031.350461.716.121,21,11522.5
TORRENT PHARMACEUTICALS LTD.26110.05510.026160.016.2812051559.7
Max Healthcare Institute Limit7738.71660.36940.21.710922191.0

Peer Comparison Chart


About CIPLA

Cipla Ltd.,, with Security Code 500087, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Company Updates


Latest News

Cipla, Biocon, Lupin, Other Pharma Stocks Under Pressure Post Trumps 100% Tariff

(26 Sep 2025)
Nifty Pharma index declined 2.67% intraday on Friday after US President Donald Trump announced a 100% tariff on the sector with an exception...
Read more →

The impact of Trump tariff on Indian Pharma is limited at best | Business News

(26 Sep 2025)
The adverse reaction of pharma stocks—from Sun Pharma to Dr Reddy's and Cipla—to 100% US tariffs on pharma imports is largely unfounded.
Read more →

Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on

(26 Sep 2025)
India Business News: Pharmaceutical stocks, particularly Indian firms, plummeted following President Trump's announcement of 100% tariffs on...
Read more →

Pharma stocks led by Natco, Wockhardt fall up to 5% after US tariffs on generic, patented drugs

(26 Sep 2025)
Indian Pharma companies, from Sun Pharma Ltd. to Aurobindo Pharma Ltd., Gland Pharma Ltd., Lupin Ltd., Cipla Ltd. among others fell up to 5%...
Read more →

Cipla, Zydus, Dr Reddy’s, and More Pharma Shares Plunge As Trump Imposes New 100% Tariff; Check Details

(26 Sep 2025)
These early losses reflect investor concerns about the recent tariff announcements impacting the pharmaceutical sector., Markets, Times Now.
Read more →

Sun Pharma, Cipla or Dr Reddy's: Which pharma major is most vulnerable to Trump's 100% tariff

(26 Sep 2025)
President Trump's imposition of 100% tariffs on branded drugs has shaken Indian pharma companies, impacting stocks like Sun Pharma, Cipla,...
Read more →